Bacterial Resistance to Gram-positive Germs at the Intensive Care Unit
Keywords:
GÉRMENES, ANTIBIÓTICOS, RESISTENCIAAbstract
The gram-positive germs are the causative agents of multiple hospital infections which are frequently serious. Among them,. The staphylococcus aureus and streptococcus have developed resistance to different antibiotics by diverse mechanisms. Others like Streptococcus pneumoniae has shown high resistance to penicillin and to other group of antibiotics. Antibiotic sensitivity routine tests are critical in all of the isolates coming from samples with clinical significance as blood culture media can be, samples of cerebrospinal fluid and other sterile fluids.Downloads
Download data is not yet available.
References
1. Starke L, Donnelly P. Antimicrobial therapy in theinmuno-compromised patient. Current Medical Literature, New York 1992:16-22.
2. Mainardi JL, Shales D. Decreased teicoplanin susceptibility of methicillin resistant strain of staphylococcusaureus. J Infect Dis 2002;171:11646-50.
3. Goodman L, Gilman A. The pharmacological basis of therapeutics. 8 ed. New York:Pergamon, 1999:1062-1086.
4. Gorbash SL, Bartlett LG. Infectious diseases. Philadelphia: WB Saunders, 2003:231-239.
5. Díaz Rubio M, Espinosa D. Tratado de medicina interna. 2 ed. Madrid: Editorial Panamericana, 1996:584-593.
6. Stein LH. Internal medicine. 4 ed. St Louis Mosby,1999:1154-1168.
7. Murray P, Baron E. Manual of clinical microbiology 6 ed. Washington DC: American Society Medical Press ASM,2000:354-357.
8. Moellering RC Jr. Monitoring serum vancomycin levels: cllimbing the mountain because there? Clin Infect Dis 2004;18:544-6.
9. Abramowicz M, ed. Handbook of antimicrobial therapy.New York: New Rochell NY Medical Letter, 1992:24-32.
10. Parrillo JE. Critical care medicine. Principles ofdiagnosis and management. St Louis: Mosby; 2003.
11. Acar J. Les infections staphylococcoques. Tempo Med 1993;502:13.
12. Goering RV, Tey PD. Usefullness of pulsed-field ge lelectrophoresis in the epidemiological analisys of staphylococcus aureus isolates with decreased susceptibility to teicoplanin. EurJ Clin Microbiol Infect Dis 1995;14:546-550.
13. Townsend G, Scheld U. Anti-inflamatory therapy for Bacterial Meningitis. Clin Inmunother 2002;3:236-238.
14. Van N, Lesput P. Nativa valve endocarditis due to nutrionally variant stafilococcus adjaacens associated withenterococcus faecium. Eur Clin Microbiol Infect Dis 2002;14.543-545.
15. Braunwald E. Heart disease. A texbook of cardiovasculas medicine. 4 ed. Philadelphia Saunders, 1992:656-662.
16. Dupont C, Valer B. Endocarditis a Corinebacterium diphteriae mitis cchez des patients non inmunodeprimos 2 casi.Rev Med Intern 1992;13:504.
17. Eliopolus G. The 10 most common questions about resistant enterococcal infectious. Infect Dis Clin Pract 2001; 3(2):236-239.
18. Gold HS, Unal S. A gene confering resistance to vancomycin but not teicoplaning in isolates of enterococcus faecalis and enterococcus faecium demostrates homology with van B, van A, van C genes of enterococcus. Antimicrob Agents Chemother 2003; 37(8):155-158.
19. Tomás A. Antimicrobial resistance. N Engl J Med 2004;17:330-333.
20. Odortholary L. Endocardite sur valve native àlactobacillus caser subespecieis casei. Mèd Nat Infect 2004; 24:110-1.
21. Collins A. In vitro activity of ramoplanin against vanncomycin resistant gram possitives organisms. Antimicrob Agents Chemother 1993; 37(6):1364-6.
22. Jacques A. Multiresitance du pneeumocoque. Un bilara léchelon mondial. Impact Mèdical Hebdo 2003; 242:24-6.
23. Goldstein F, Acar J. Comparative activity of teicoplanin and vancomycin against 400 penicilin susceptible andresistant streptococcus pneumoniae. Eur J Clin Microbiol InfectDis 2000;13:116-124.
24. Ban N, Nissen P, Hansen J, Moore PB, Steitz TA. The complete atomic structure of the large ribosomal subunit at 2.4 A resolution. Science 2000; 289:905-920.
25. Barnett ED, Klein JO. The problem of resistant bacteria for the management of acute otitis media. Pediatr Clin North Am 1995;42:509-517.
26. Bartlett JG, Breiman RF, Mandell LA, File TM Jr. Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis 1998; 26:811-838.
27. Bisno AL. Acute pharyngitis. N Engl J Med 2001; 344:205-211.
28. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000; 19:187-195.
29. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994; 271:1831-1835.
30. Buckingham SC, Brown SP, Joaquin VH. Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia. J Pediatr 1998;132:174-176.
31. Catalan MJ, Fernandez JM, Vazquez A, Varela de Seijas E, Suarez A, Bernaldo de Quiros JC. Failure of cefotaxime in the treatment of meningitis due to.
2. Mainardi JL, Shales D. Decreased teicoplanin susceptibility of methicillin resistant strain of staphylococcusaureus. J Infect Dis 2002;171:11646-50.
3. Goodman L, Gilman A. The pharmacological basis of therapeutics. 8 ed. New York:Pergamon, 1999:1062-1086.
4. Gorbash SL, Bartlett LG. Infectious diseases. Philadelphia: WB Saunders, 2003:231-239.
5. Díaz Rubio M, Espinosa D. Tratado de medicina interna. 2 ed. Madrid: Editorial Panamericana, 1996:584-593.
6. Stein LH. Internal medicine. 4 ed. St Louis Mosby,1999:1154-1168.
7. Murray P, Baron E. Manual of clinical microbiology 6 ed. Washington DC: American Society Medical Press ASM,2000:354-357.
8. Moellering RC Jr. Monitoring serum vancomycin levels: cllimbing the mountain because there? Clin Infect Dis 2004;18:544-6.
9. Abramowicz M, ed. Handbook of antimicrobial therapy.New York: New Rochell NY Medical Letter, 1992:24-32.
10. Parrillo JE. Critical care medicine. Principles ofdiagnosis and management. St Louis: Mosby; 2003.
11. Acar J. Les infections staphylococcoques. Tempo Med 1993;502:13.
12. Goering RV, Tey PD. Usefullness of pulsed-field ge lelectrophoresis in the epidemiological analisys of staphylococcus aureus isolates with decreased susceptibility to teicoplanin. EurJ Clin Microbiol Infect Dis 1995;14:546-550.
13. Townsend G, Scheld U. Anti-inflamatory therapy for Bacterial Meningitis. Clin Inmunother 2002;3:236-238.
14. Van N, Lesput P. Nativa valve endocarditis due to nutrionally variant stafilococcus adjaacens associated withenterococcus faecium. Eur Clin Microbiol Infect Dis 2002;14.543-545.
15. Braunwald E. Heart disease. A texbook of cardiovasculas medicine. 4 ed. Philadelphia Saunders, 1992:656-662.
16. Dupont C, Valer B. Endocarditis a Corinebacterium diphteriae mitis cchez des patients non inmunodeprimos 2 casi.Rev Med Intern 1992;13:504.
17. Eliopolus G. The 10 most common questions about resistant enterococcal infectious. Infect Dis Clin Pract 2001; 3(2):236-239.
18. Gold HS, Unal S. A gene confering resistance to vancomycin but not teicoplaning in isolates of enterococcus faecalis and enterococcus faecium demostrates homology with van B, van A, van C genes of enterococcus. Antimicrob Agents Chemother 2003; 37(8):155-158.
19. Tomás A. Antimicrobial resistance. N Engl J Med 2004;17:330-333.
20. Odortholary L. Endocardite sur valve native àlactobacillus caser subespecieis casei. Mèd Nat Infect 2004; 24:110-1.
21. Collins A. In vitro activity of ramoplanin against vanncomycin resistant gram possitives organisms. Antimicrob Agents Chemother 1993; 37(6):1364-6.
22. Jacques A. Multiresitance du pneeumocoque. Un bilara léchelon mondial. Impact Mèdical Hebdo 2003; 242:24-6.
23. Goldstein F, Acar J. Comparative activity of teicoplanin and vancomycin against 400 penicilin susceptible andresistant streptococcus pneumoniae. Eur J Clin Microbiol InfectDis 2000;13:116-124.
24. Ban N, Nissen P, Hansen J, Moore PB, Steitz TA. The complete atomic structure of the large ribosomal subunit at 2.4 A resolution. Science 2000; 289:905-920.
25. Barnett ED, Klein JO. The problem of resistant bacteria for the management of acute otitis media. Pediatr Clin North Am 1995;42:509-517.
26. Bartlett JG, Breiman RF, Mandell LA, File TM Jr. Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis 1998; 26:811-838.
27. Bisno AL. Acute pharyngitis. N Engl J Med 2001; 344:205-211.
28. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000; 19:187-195.
29. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994; 271:1831-1835.
30. Buckingham SC, Brown SP, Joaquin VH. Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia. J Pediatr 1998;132:174-176.
31. Catalan MJ, Fernandez JM, Vazquez A, Varela de Seijas E, Suarez A, Bernaldo de Quiros JC. Failure of cefotaxime in the treatment of meningitis due to.
Downloads
How to Cite
1.
Muara Álvarez HD, Hernández Morgado JM, Villamil Fumero K. Bacterial Resistance to Gram-positive Germs at the Intensive Care Unit. Mediciego [Internet]. 2004 Oct. 22 [cited 2026 Feb. 4];10. Available from: https://revmediciego.sld.cu/index.php/mediciego/article/view/2679
Issue
Section
Review article
License
Those authors who have publications with this journal accept the following terms of the License CC Attribution-NonCommercial 4.0 International (CC BY-NC 4.0):
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
The journal is not responsible for the opinions and concepts expressed in the works, which are the exclusive responsibility of the authors. The Editor, with the assistance of the Editorial Committee, reserves the right to suggest or request advisable or necessary modifications. Original scientific works are accepted for publication, as are the results of research of interest that have not been published or sent to another journal for the same purpose.
The mention of trademarks of specific equipment, instruments or materials is for identification purposes, and there is no promotional commitment in relation to them, neither by the authors nor by the editor.
